G1 Therapeutics, Inc.·4

Mar 22, 4:10 PM ET

Thomas Monica R. 4

4 · G1 Therapeutics, Inc. · Filed Mar 22, 2024

Insider Transaction Report

Form 4
Period: 2024-03-20
Thomas Monica R.
General Counsel
Transactions
  • Award

    Common Stock

    2024-03-20+37,500115,651 total
Footnotes (3)
  • [F1]Represents a restricted stock unit ("RSU") award that vests 50% on March 20, 2025 and 50% on March 20, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
  • [F3]Represents (i) 176 shares of common stock; (ii) 50,000 RSUs from award granted on May 22, 2023; (iii) 27,975 RSUs from award granted on January 3, 2024; and (iv) 37,500 RSUs from award granted on March 20, 2024.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT